ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 260 out of 783

$400K Total Retail Price of All Prescriptions

Rank: 362 out of 783

401 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 401 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,880 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 428 315 S3 1 2
FUROSEMIDE 387 318 2 7
WARFARIN SODIUM 272 134 3 10
LEVOTHYROXINE SODIUM 246 182 4 1
LISINOPRIL 244 147 5 4
POTASSIUM CHLORIDE 242 195 6 16
DONEPEZIL HCL 188 173 7 24
NAMENDA 179 177 8 32
METOPROLOL TARTRATE 176 104 9 9
OMEPRAZOLE 176 128 9 6
METFORMIN HCL 173 103 11 8
AMLODIPINE BESYLATE 148 81 12 5
CARVEDILOL 141 106 13 21
SIMVASTATIN 138 79 14 3
FAMOTIDINE 130 79 15 55
POLYETHYLENE GLYCOL 3350 125 104 16 43
QUETIAPINE FUMARATE 117 85 17 79
SERTRALINE HCL 107 70 18 22
PANTOPRAZOLE SODIUM 106 78 19 30
TRAMADOL HCL 99 83 20 20
MELOXICAM 90 75 21 37
PREDNISONE 79 69 22 36
DIGOXIN 77 60 23 61
MIRTAZAPINE 73 73 24 52
CITALOPRAM HBR 71 57 25 19
IPRATROPIUM-ALBUTEROL 70 67 26 110
DILTIAZEM 24HR CD 66 66 27 118
ESCITALOPRAM OXALATE 65 53 28 54
CARBIDOPA-LEVODOPA 65 48 28 88
CEPHALEXIN 62 43 30 70
LYRICA 60 48 31 98
SEROQUEL 57 43 32 183
ATORVASTATIN CALCIUM 56 39 33 11
CIPROFLOXACIN HCL 56 49 33 62
RISPERIDONE 54 52 35 67
TAMSULOSIN HCL 53 50 36 26
GABAPENTIN 52 21 37 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 31, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.